3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
5
Obesity
5
Sexual Infantilism
4
Craniopharyngioma
3
Overweight
2
Weight Loss
1
Pancreatic Neoplasms
1
Insulin Resistance
1
Fatty Liver
1
Diabetes Mellitus, Type 2
1
Diabetes Mellitus, Type 1
1
Interventions
Glucose Tolerance Test
2
penclomedine
1
Triptorelin Pamoate
1
Proton Magnetic Resonance Spectroscopy
1
Pancreaticoduodenectomy
1
Orchiectomy
1
Olive Oil
1
Exenatide
1
Excitatory Amino Acids
1
Amino Acids, Essential
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Fatty Liver
×
Exenatide
×
Clear all
NCT02157974
2024-06-04
APPLE
University of Colorado, Denver
Phase 2/3
Completed
92 enrolled
17 charts